Skip to content
10-Q

Quarterly Report

NGM BIOPHARMACEUTICALS INC

0001628280-23-036401

← back to feed
Filed
Nov 2, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 30, 2023 82.72M sh
Shares Diluted Q3 2023 · Sep 30, 2023 82.71M sh
Shares Diluted Q3 2023 · Sep 30, 2023 82.39M sh
Shares Diluted Q3 2023 · Sep 30, 2022 80.62M sh
Shares Diluted Q3 2023 · Sep 30, 2022 79.33M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$109.24M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$114.04M
Short Term Investments Q3 2023 · Sep 30, 2023 $114.57M
Short Term Investments Q3 2023 · Dec 31, 2022 $198.04M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $51.48M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $73.46M
Stockholders Equity Q3 2023 · Sep 30, 2023 $169.81M
Stockholders Equity Q3 2023 · Jun 30, 2023 $192.12M
Stockholders Equity Q3 2023 · Mar 31, 2023 $220.93M
Stockholders Equity Q3 2023 · Dec 31, 2022 $259.56M
Stockholders Equity Q3 2023 · Sep 30, 2022 $285.89M
Stockholders Equity Q3 2023 · Jun 30, 2022 $292.08M
Stockholders Equity Q3 2023 · Mar 31, 2022 $311.14M
Stockholders Equity Q3 2023 · Dec 31, 2021 $335.65M
Current Liabilities Q3 2023 · Sep 30, 2023 $22.35M
Current Liabilities Q3 2023 · Dec 31, 2022 $47.84M
Total Liabilities Q3 2023 · Sep 30, 2023 $22.35M
Total Liabilities Q3 2023 · Dec 31, 2022 $47.84M
Current Assets Q3 2023 · Sep 30, 2023 $177.04M
Current Assets Q3 2023 · Dec 31, 2022 $288.86M
Total Assets Q3 2023 · Sep 30, 2023 $192.15M
Total Assets Q3 2023 · Dec 31, 2022 $307.4M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.35
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.39
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.59
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.59
Eps Basic Q3 2023 · Sep 30, 2023 −$0.35
Eps Basic Q3 2023 · Sep 30, 2023 −$1.39
Eps Basic Q3 2023 · Sep 30, 2022 −$0.59
Eps Basic Q3 2023 · Sep 30, 2022 −$1.59
Sga Expense Q3 2023 · Sep 30, 2023 $8.67M
Sga Expense Q3 2023 · Sep 30, 2023 $29.9M
Sga Expense Q3 2023 · Sep 30, 2022 $10.11M
Sga Expense Q3 2023 · Sep 30, 2022 $30.76M
Rd Expense Q3 2023 · Sep 30, 2023 $22.94M
Rd Expense Q3 2023 · Sep 30, 2023 $96.15M
Rd Expense Q3 2023 · Sep 30, 2022 $46.11M
Rd Expense Q3 2023 · Sep 30, 2022 $134.35M
Net Income Q3 2023 · Sep 30, 2023 −$28.8M
Net Income Q3 2023 · Sep 30, 2023 −$114.71M
Net Income Q3 2023 · Jun 30, 2023 −$38.26M
Net Income Q3 2023 · Mar 31, 2023 −$47.65M
Net Income Q3 2023 · Sep 30, 2022 −$47.26M
Net Income Q3 2023 · Sep 30, 2022 −$126.23M
Net Income Q3 2023 · Jun 30, 2022 −$46.52M
Net Income Q3 2023 · Mar 31, 2022 −$32.45M
Operating Income Q3 2023 · Sep 30, 2023 −$31.03M
Operating Income Q3 2023 · Sep 30, 2023 −$121.8M
Operating Income Q3 2023 · Sep 30, 2022 −$48.3M
Operating Income Q3 2023 · Sep 30, 2022 −$127.95M
Revenue Q3 2023 · Sep 30, 2023 $582K
Revenue Q3 2023 · Sep 30, 2023 $4.25M
Revenue Q3 2023 · Sep 30, 2022 $7.91M
Revenue Q3 2023 · Sep 30, 2022 $37.15M